StockData
IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF

IMMUTEP Ltd

Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Oct 24, 2025
$3.17−0.03 (-0.94%)

Close on Oct 19, 2026

IMMUTEP Ltd revenue by segment

No segment breakdown reported

Immutep does not break out revenue by segment, region or product in the tagged data of its filings for this period type.